Workflow
融资融券
icon
Search documents
耐科装备12月31日获融资买入116.92万元,融资余额5374.95万元
Xin Lang Cai Jing· 2026-01-05 01:47
Core Viewpoint - The company, NAIKE Equipment, has shown a decline in stock performance with a slight drop of 0.04% on December 31, and the financing data indicates a net outflow of funds, suggesting potential liquidity concerns [1] Group 1: Financial Performance - For the period from January to September 2025, NAIKE Equipment achieved a revenue of 220 million yuan, representing a year-on-year growth of 11.59% [2] - The net profit attributable to the parent company for the same period was 66.24 million yuan, reflecting a year-on-year increase of 14.70% [2] - Cumulative cash dividends since the company's A-share listing amount to 81.75 million yuan [3] Group 2: Shareholder and Market Data - As of September 30, 2025, the number of shareholders for NAIKE Equipment was 6,865, an increase of 28.56% compared to the previous period [2] - The average number of circulating shares per shareholder is 4,482, which is an increase of 8.03% from the last period [2] - The financing balance of NAIKE Equipment is 53.75 million yuan, accounting for 3.23% of the circulating market value, which is below the 20th percentile level over the past year, indicating a low financing position [1]
天德钰12月31日获融资买入548.57万元,融资余额2.88亿元
Xin Lang Cai Jing· 2026-01-05 01:44
12月31日,天德钰跌1.17%,成交额6011.90万元。两融数据显示,当日天德钰获融资买入额548.57万 元,融资偿还728.57万元,融资净买入-180.00万元。截至12月31日,天德钰融资融券余额合计2.88亿 元。 融资方面,天德钰当日融资买入548.57万元。当前融资余额2.88亿元,占流通市值的7.47%,融资余额 超过近一年60%分位水平,处于较高位。 截至9月30日,天德钰股东户数1.62万,较上期增加19.11%;人均流通股11225股,较上期减少16.04%。 2025年1月-9月,天德钰实现营业收入16.98亿元,同比增长14.44%;归母净利润1.95亿元,同比增长 1.67%。 分红方面,天德钰A股上市后累计派现5196.62万元。 机构持仓方面,截止2025年9月30日,天德钰十大流通股东中,香港中央结算有限公司位居第三大流通 股东,持股611.10万股,相比上期增加236.70万股。南方中证1000ETF(512100)位居第七大流通股 东,持股111.85万股,相比上期增加9616.00股。南方科创板3年定开混合(506000)退出十大流通股东 之列。 责任编辑:小浪快报 ...
森鹰窗业12月31日获融资买入1181.52万元,融资余额2.22亿元
Xin Lang Cai Jing· 2026-01-05 01:44
Group 1 - The core viewpoint of the news highlights the financial performance and trading activity of Senying Windows, indicating a significant increase in stock price and trading volume on December 31, with a 4.35% rise and a transaction amount of 97.76 million yuan [1] - As of December 31, the financing balance of Senying Windows reached 222 million yuan, accounting for 11.63% of its market capitalization, which is above the 80th percentile of the past year, indicating a high level of financing activity [1] - The company reported a revenue of 439 million yuan for the first nine months of 2025, reflecting a year-on-year growth of 16.40%, while the net profit attributable to the parent company was a loss of 20.30 million yuan, but this still represented a 37.42% improvement compared to the previous period [2] Group 2 - Senying Windows has distributed a total of 141 million yuan in dividends since its A-share listing [3] - The number of shareholders as of September 30 was 4,344, a decrease of 34.12% from the previous period, while the average circulating shares per person increased by 51.27% to 7,784 shares [2]
骄成超声12月31日获融资买入3080.91万元,融资余额3.79亿元
Xin Lang Cai Jing· 2026-01-05 01:44
Core Viewpoint - The company, Shanghai Jiao Cheng Ultrasonic Technology Co., Ltd., has shown significant growth in revenue and net profit, indicating strong operational performance in the ultrasonic equipment sector [2]. Group 1: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 521 million yuan, representing a year-on-year growth of 27.53% [2]. - The net profit attributable to the parent company reached 94.03 million yuan, marking a substantial increase of 359.81% year-on-year [2]. - As of December 31, the company’s financing balance was 379 million yuan, accounting for 2.92% of its market capitalization, which is above the 90th percentile of the past year [1]. Group 2: Shareholder Information - As of September 30, 2025, the number of shareholders increased to 8,133, up by 71.84% from the previous period [2]. - The average circulating shares per person decreased by 4.81% to 14,230 shares [2]. - The company has distributed a total of 167 million yuan in dividends since its A-share listing [3]. Group 3: Market Activity - On December 31, the company’s stock price fell by 2.00%, with a trading volume of 284 million yuan [1]. - The financing buy amount on that day was 30.81 million yuan, while the financing repayment was 31.29 million yuan, resulting in a net financing outflow of 479,300 yuan [1]. - The company had a total of 3,400 shares available for short selling, with a short selling balance of 381,500 yuan, which is below the 50th percentile of the past year [1].
天力锂能12月31日获融资买入545.11万元,融资余额1.19亿元
Xin Lang Cai Jing· 2026-01-05 01:44
Group 1 - The core viewpoint of the news is that Tianli Lithium Energy experienced a decline in stock price and significant changes in financing activities as of December 31, with a net financing outflow of 525.64 million yuan [1] - On December 31, Tianli Lithium Energy's stock price fell by 1.64%, with a trading volume of 95.21 million yuan, and the total financing and margin trading balance reached 119 million yuan [1] - The company has a high financing balance, accounting for 5.40% of its market capitalization, which is above the 60th percentile of the past year [1] Group 2 - As of September 30, the number of shareholders of Tianli Lithium Energy increased by 4.71% to 18,200, while the average number of circulating shares per person decreased by 4.53% to 3,899 shares [2] - For the period from January to September 2025, Tianli Lithium Energy reported a revenue of 1.535 billion yuan, representing a year-on-year growth of 11.18%, while the net profit attributable to the parent company was -89.74 million yuan, an increase of 47.42% year-on-year [2] - Since its A-share listing, Tianli Lithium Energy has distributed a total of 36.59 million yuan in dividends [2]
德邦科技12月31日获融资买入1406.46万元,融资余额3.14亿元
Xin Lang Cai Jing· 2026-01-05 01:44
Group 1 - The core viewpoint of the news is that Debang Technology has shown fluctuations in its stock performance and financing activities, with a notable increase in revenue and net profit year-on-year [1][2]. Group 2 - On December 31, Debang Technology's stock fell by 1.09%, with a trading volume of 109 million yuan. The financing buy-in amount was 14.06 million yuan, while the financing repayment was 16.59 million yuan, resulting in a net financing buy of -2.52 million yuan [1]. - As of December 31, the total balance of margin trading for Debang Technology was 314 million yuan, accounting for 4.58% of its market capitalization, which is above the 60th percentile level over the past year [1]. - The company had no shares sold short on December 31, with a short selling balance of 31.97 million yuan, exceeding the 90th percentile level over the past year [1]. Group 3 - As of September 30, the number of shareholders of Debang Technology increased by 10.30% to 11,700, with an average of 12,171 circulating shares per person, up by 45.20% [2]. - For the period from January to September 2025, Debang Technology achieved a revenue of 1.09 billion yuan, representing a year-on-year growth of 39.01%, and a net profit attributable to shareholders of 69.75 million yuan, up by 15.39% [2]. Group 4 - Since its A-share listing, Debang Technology has distributed a total of 127 million yuan in dividends [3]. - As of September 30, 2025, Hong Kong Central Clearing Limited and GF Electronic Information Media Stock A (005310) have exited the list of the top ten circulating shareholders of Debang Technology [3].
聚胶股份12月31日获融资买入617.27万元,融资余额4113.57万元
Xin Lang Cai Jing· 2026-01-05 01:43
Core Viewpoint - The company, 聚胶股份, has shown a mixed performance in terms of financing activities and stockholder metrics, with notable growth in revenue and net profit year-over-year, indicating potential investment opportunities. Financing Activities - On December 31, 聚胶股份 experienced a financing buy-in of 6.17 million yuan, while financing repayments amounted to 8.76 million yuan, resulting in a net financing outflow of 2.58 million yuan [1] - The total financing and margin trading balance as of December 31 was 41.45 million yuan, with the financing balance of 41.14 million yuan representing 1.75% of the circulating market value, which is below the 10th percentile level over the past year, indicating a low financing level [1] - The company had no short-selling activity on December 31, with a short-selling balance of 310,600 yuan, which is above the 90th percentile level over the past year, suggesting a high level of short interest [1] Financial Performance - For the period from January to September 2025, 聚胶股份 reported a revenue of 1.539 billion yuan, reflecting a year-over-year growth of 6.28% [2] - The net profit attributable to the parent company for the same period was 142 million yuan, showing a significant year-over-year increase of 111.68% [2] Shareholder Metrics - As of September 30, 2025, the number of shareholders for 聚胶股份 was 6,404, a decrease of 19.47% compared to the previous period [2] - The average number of circulating shares per shareholder increased by 24.11% to 7,155 shares [2] - Cumulatively, the company has distributed 187 million yuan in dividends since its A-share listing [3] - Among the top ten circulating shareholders, the fund 鹏华弘嘉混合A (003165) held 745,100 shares, a decrease of 132,100 shares from the previous period [3]
中荣股份12月31日获融资买入111.31万元,融资余额3588.45万元
Xin Lang Cai Jing· 2026-01-05 01:43
Group 1 - The core viewpoint of the news is that Zhongrong Co., Ltd. has shown a mixed performance in terms of financing and stock trading, with a notable increase in revenue and net profit year-on-year [1][2][3] Group 2 - As of December 31, Zhongrong's stock price increased by 0.33%, with a trading volume of 21.61 million yuan. The financing buy-in amount was 1.11 million yuan, while the financing repayment was 1.87 million yuan, resulting in a net financing buy of -0.75 million yuan [1] - The total financing and securities balance for Zhongrong as of December 31 was 35.88 million yuan, which accounts for 1.74% of the circulating market value, indicating a low level compared to the past year [1] - The company had no short-selling activity on December 31, with a short-selling balance of 0.00 shares, which is at a high level compared to the past year [1] Group 3 - As of November 30, the number of shareholders for Zhongrong was 17,000, with an average of 6,589 circulating shares per person, showing no change from the previous period [2] - For the period from January to September 2025, Zhongrong achieved an operating income of 2.26 billion yuan, representing a year-on-year growth of 17.25%, and a net profit attributable to shareholders of 132 million yuan, up 19.84% year-on-year [2] Group 4 - Since its A-share listing, Zhongrong has distributed a total of 168 million yuan in dividends [3] - As of September 30, 2025, among the top ten circulating shareholders, two new institutional shareholders, including招商量化精选股票发起式A and 招商成长量化选股股票A, have significant holdings [3]
华大智造12月31日获融资买入730.15万元,融资余额3.92亿元
Xin Lang Cai Jing· 2026-01-05 01:43
Group 1 - The core viewpoint of the news is that BGI Genomics has shown fluctuations in its stock performance and financing activities, indicating a mixed market sentiment towards the company [1][2]. - As of December 31, BGI Genomics' stock price increased by 0.07%, with a trading volume of 96.99 million yuan. The net financing buy was -834,600 yuan, indicating more repayments than new purchases [1]. - The total balance of margin trading for BGI Genomics reached 398 million yuan, with a financing balance of 392 million yuan, accounting for 1.56% of the circulating market value, which is above the 60th percentile of the past year [1]. Group 2 - As of September 30, the number of shareholders for BGI Genomics increased to 15,400, a rise of 14.17%, with an average of 26,794 circulating shares per person, up by 69.94% [2]. - For the period from January to September 2025, BGI Genomics reported an operating income of 1.869 billion yuan, a slight decrease of 0.01% year-on-year, while the net profit attributable to shareholders was -120 million yuan, reflecting a significant increase of 74.20% year-on-year [2]. - Since its A-share listing, BGI Genomics has distributed a total of 150 million yuan in dividends [3].
汉仪股份12月31日获融资买入852.06万元,融资余额2.92亿元
Xin Lang Cai Jing· 2026-01-05 01:41
12月31日,汉仪股份涨0.78%,成交额1.18亿元。两融数据显示,当日汉仪股份获融资买入额852.06万 元,融资偿还1168.15万元,融资净买入-316.09万元。截至12月31日,汉仪股份融资融券余额合计2.93 亿元。 融资方面,汉仪股份当日融资买入852.06万元。当前融资余额2.92亿元,占流通市值的7.82%,融资余 额超过近一年60%分位水平,处于较高位。 融券方面,汉仪股份12月31日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00 元;融券余量7000.00股,融券余额26.17万元,超过近一年90%分位水平,处于高位。 资料显示,北京汉仪创新科技股份有限公司位于北京市海淀区翠微路2号院五区2号楼二层201,成立日 期1993年9月4日,上市日期2022年8月31日,公司主营业务涉及字体设计、字库软件开发和授权、提供 字库类技术服务和视觉设计服务,以及以IP赋能方式开展的IP产品化业务。主营业务收入构成为:字库 软件授权业务68.01%,互联网平台授权业务23.20%,字库类技术服务业务6.15%,IP产品及授权等业务 1.75%,其他技术服务业务0.87%, ...